Atezolizumab Plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma Progressing after Molecular Targeted Therapy: A Multicenter Prospective Observational StudyRie Sugimoto,Takeaki Satoh,Akihiro Ueda,Takeshi Senju,Yuki Tanaka,Shinsaku Yamashita,Toshimasa Koyanagi,Tomoyuki Kurashige,Nobito Higuchi,Tsukasa Nakamura,Masatake Tanaka, Yuuki Azuma,Akari Ohno,Aritsune Ooho,Mari Ooe,Taiji Mutsuki,Koutarou Uchimura,Masami Kuniyoshi,Seiya Tada,Yoshifusa Aratake,Tsuyoshi Yoshimoto,Naoki Yamashita,Shigeru Harada,Makoto Nakamuta,Kenta Motomura,Motoyuki KohjimaMedicine（2022）引用 3|浏览15暂无评分关键词atezolizumab plus bevacizumab,hepatocellular carcinoma,RECIST,mRECIST,MTA pretreatmentAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
